Document:

EX-10.1

EXHIBIT 10.1

	 	 	 
	FROM:

TO:

DATE:
	 	Citibank Europe plc (the “Bank”)

Renaissance Reinsurance Ltd., DaVinci Reinsurance Ltd. (the “Original

Companies”) and RenaissanceRe Specialty U.S. Ltd., Renaissance

Reinsurance of Europe, and Renaissance Reinsurance U.S. Inc. (formerly

Platinum Underwriters Reinsurance, Inc.) (the “Additional Companies”

and, together with the Original Companies, the “Companies”)

31st December, 2016

Ladies and Gentlemen,

The Facility Letter dated 17 September 2010 between (1) the Bank and (2) the Companies regarding a
committed letter of credit issuance facility in a maximum aggregate amount of USD 300,000,000, as
amended by Letter Amendment dated 14th July 2011, 1st October, 2013,
23rd December 2014 and 31st March 2015, 30th December 2015 and
14th January 2016 and as may be further amended, varied, supplemented, novated or
assigned from time to time (the “Facility Letter”).

	1.	 	We refer to the Facility Letter. Capitalised terms used in this letter shall have the
meanings given to them in the Facility Letter (including where defined in the Facility Letter
by reference to another document).

	2.	 	The following amendments shall take effect on and from the date that the Bank receives this
letter duly executed by the Companies (“Effective Date”).

	3.	 	The Bank and the Companies agree, for good and valuable consideration, the receipt and legal
sufficiency of which are hereby acknowledged, that as effective from the date of this letter:

	 	(i)	 	Clause 1.1 of the Facility Letter shall be amended and restated in its entirety
as follows:

	 	 	 	“Further to recent conversations, Citibank Europe plc (the “Bank”) is pleased to
provide a committed letter of credit issuance facility (the “Facility”) up until
31 December 2018 (the “Termination Date”) to the Companies subject to the terms
and conditions set out in this Letter. Unless otherwise defined herein,
capitalised terms used in this Letter are as defined in Clause 14.”

	4.	 	Except as expressly amended by this letter, the Facility Letter remains unmodified and in
full force and effect. In the event of a conflict or inconsistency between the terms of this
letter and the terms of the Facility letter, the terms of this letter shall prevail.

	5.	 	The provisions contained in clause 6, Interest, and clause 7, Fees, in the Facility Letter
shall apply in relation to the amendments agreed pursuant to the terms of this letter. Each
party to this letter shall bear its own costs and expenses in relation to the amendments
agreed pursuant to the terms of this letter.

	6.	 	On the date of this letter and on the Effective Date, each Original Company, as to itself,
hereby confirms to the Bank that the representations and warranties set forth in clause 8 of
the Facility Letter are true.

	7.	 	With effect from the Effective Date of this letter, the terms and conditions of the Facility
Letter shall be read and construed by reference to this letter and all references to the
Facility Letter shall be deemed to incorporate the relevant amendments contained within this
letter.

	8.	 	This letter may be executed in counterparts, each of which shall be deemed to be an original,
and all such counterparts taken together shall constitute one and the same agreement. This
letter and any non-contractual obligations arising in connection with it shall be governed by
English law and the provisions of Clause 16 (Governing Law) of the Facility Letter shall be
incorporated, with any necessary changes, as if set out in full in this letter. No person
shall have any right to enforce any provision of this letter under the Contracts (Rights of
Third Parties) Act 1999.

	9.	 	Please indicate your agreement to the foregoing by countersigning the attached copy of this
letter and returning the same to us.

[signature page follows]

For and of behalf of

Citibank Europe plc

/s/ Niall Tuckey

Name: Niall Tuckey

Title: Director

We agree to the terms set out in this letter.

For and of behalf of

Renaissance Reinsurance Ltd.

/s/ Mark A. Wilcox

Name: Mark A. Wilcox

Title: Senior Vice President

For and of behalf of

DaVinci Reinsurance Ltd.

/s/ Aditya K. Dutt

Name: Aditya K. Dutt

Title: President

For and of behalf of

RenaissanceRe Specialty U.S. Ltd.

/s/ David Marra

Name: David Marra

Title: President

For and of behalf of

Renaissance Reinsurance of Europe

/s/ Sean Brosnan

Name: Sean Brosnan

Title: Managing Director

For and of behalf of

Renaissance Reinsurance U.S. Inc.

/s/ James M. Conway

Name: James M. Conway

Title: Senior Vice PresidentWARRANT AGREEMENT

This Warrant Agreement
(the “Agreement”) made as of December 30, 2016, between GREENESTONE HEALTHCARE CORPORATION, a Colorado corporation,
with headquarters at 5734 Yonge Street, Suite 300, North York, Ontario, Canada M2M 4E7 (“Company”), and _________________________________________________________
(“Warrant Holder”).

 

WHEREAS, the Company
has determined to issue warrants to each holder of its Series L Convertible Notes in the principle amount of each Note (the “Warrants”),
each of such Warrants evidencing the right of the holder thereof to purchase one share of the Company’s common stock (the
“Common Stock”), for $0.03, subject to adjustment as described herein exercisable for 3 years from issuance; and

WHEREAS, the Company
desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the
respective rights, limitation of rights, and immunities of the Company, and the holders of the Warrants; and

WHEREAS, all acts
and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned
by the Warrant holder, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution
and delivery of this Agreement.

NOW, THEREFORE,
in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

1.    
Warrants.

1.1.        
Form of Warrant. Each Warrant shall be in substantially the form of Exhibit A hereto, the provisions of which are
incorporated herein, and may have such letters, numbers or other marks of identification or designation and such legends summaries
or endorsements printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with
the provisions of this Agreement, or as may be required to comply with any law or with any rule or regulation made pursuant thereto.
Each Warrant shall be dated the date of issuance thereof and shall be signed by, or bear the facsimile signature of, the Chairman
of the Board or President and Treasurer, Secretary or Assistant Secretary of the Company and shall bear a facsimile of the Company’s
seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity
in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had
not ceased to be such at the date of issuance.

1.2.        
Effect of Countersignature. Unless and until countersigned by the Company pursuant to this Agreement, a Warrant shall be
invalid and of no effect and may not be exercised by the holder thereof. After countersignature by the Company, each Warrant shall
be delivered to the Registered Holder (as defined herein) without further action by the Company, except as otherwise provide herein.

2.    
Terms and Exercise of Warrants.

2.1.        
Warrant Price. Each Warrant shall entitle the registered holder thereof, subject to the provisions of such Warrant and
of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $0.03
per share, subject to the adjustments provided in Section 4 hereof (the “Warrant Price”).

2.2.        
Duration of Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing on December
30, 2016 and terminating at 5:00 p.m., Denver, Colorado time on December 30, 2019 (the “Expiration Date”), provided
that if either such date shall in The State of Colorado be a holiday or a day on which banks are authorized to close, then 5:00
p.m., Denver, Colorado time, on the next following day which in the State of Colorado is not a holiday or a day on which banks
are authorized to close. Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder
and all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration Date.

2.3.        
Exercise of Warrants.

2.3.1.    
Payment. Subject to the provisions of the Warrant and this Warrant Agreement, a Warrant may be exercised in whole or in
part so long as any exercise in part hereof would not involve the issuance of fractional shares of Common Stock by the registered
holder thereof by surrendering it, at the office of the Company with the form of exercise, as set forth in the Warrant, duly executed,
and by paying in full, in lawful money of the United States, in good certified check or good bank draft payable to the order of
the Company (or as otherwise agreed to by the Company), the Warrant Price for each full share of Common Stock as to which the
Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the
Warrant for the Common Stock, and the issuance of the Common Stock.

    	 	
1
	 

    	 

    

2.3.2.    
Issuance of Certificates. As soon as practicable on or after the Exercise Date, the Company, shall cause to be issued and
delivered a certificate or certificates for the number of full shares of Common Stock to the person or persons entitled to receive
the same, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised
in full, a new countersigned Warrant for the number of shares as to which such Warrant shall not have been exercised. Warrants
may not be exercised by, or securities issued to, any Registered Holder in any state in which such exercise would be unlawful.

2.3.3.    
Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement
shall be validly issued, fully paid and nonassessable.

2.3.4.    
Date of Issuance. Each person in whose name any such certificate for shares of Common Stock is issued shall for all purposes
be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered and payment of the
Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and
payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder
of such shares at the close of business on the next succeeding date on which the stock transfer books are open.

3.    
Adjustments.

3.1.        
Recapitalization, Reclassification and Succession. If any recapitalization of the Company or reclassification of its
Common Stock or any merger or consolidation of the Company into or with a Person (as defined herein), or the sale or transfer
of all or substantially all of the Company’s assets or of any successor corporation’s assets to any Person (any such
Person being included within the meaning of the term “successor corporation”) shall be effected, at any time while
any of the Warrants remain outstanding and unexpired, then, as a condition of such recapitalization, reclassification, merger,
consolidation, sale or transfer, lawful and adequate provision shall be made whereby the Warrant holders thereafter shall have
the right to receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of
Common Stock immediately theretofore issuable upon the exercise of the rights represented thereby, such shares of capital stock,
securities or other property as may be issued or payable with respect to or in exchange for a number of outstanding shares of
Common Stock equal to the number of shares of Common Stock immediately theretofore issuable upon the exercise of the Warrants
had such recapitalization, reclassification, merger, consolidation, sale or transfer not taken place, and in each such case, the
terms of this Warrant shall be applicable to the shares of stock or other securities or property receivable upon the exercise
of this Warrant after such consummation. “Person” shall mean any corporation, division of a corporation, partnership,
limited liability company, trust, joint venture, association, company, unincorporated organization, or any other entity.

3.2.        
Subdivision or Combination of Shares. If after the date hereof, the Company shall subdivide or combine its Common Stock,
the number of shares of Common Stock issuable upon exercise of each Warrant and the Warrant Price shall be proportionately adjusted.

3.3.        
Stock Dividends and Distributions. If after the date hereof, the Company shall issue or pay the holders of its Common Stock,
or take a record of the holders of its Common Stock for the purpose of entitling them to receive, a dividend payable in, or other
distribution of, Common Stock, then (i) the Warrant Price shall be adjusted in accordance with Section 3.5 and (ii) the number
of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted to the number of shares of Common Stock that
such Warrant holder would have owned immediately following such action had this Warrant been exercised immediately prior thereto.

3.4.        
Stock and Rights Offering to Stockholders. If the Company shall at any time after the date hereof, distribute to all holders
of its Common Stock any shares of capital stock of the Company (other than Common Stock) or evidences of its indebtedness or assets
(excluding cash dividends or distributions paid from retained earnings or current year’s or prior year’s earnings
of the Company) or rights or warrants to subscribe for or purchase any of its securities (excluding those referred to in the immediately
preceding paragraph) (any of the foregoing being hereinafter in this paragraph called the “Securities”), then in each
such case, the Company shall reserve shares or other units of such Securities for distribution to the Warrant holders upon exercise
of each Warrant so that, in addition to the shares of the Common Stock to which such Warrant holder is entitled, such Warrant
holder will receive upon such exercise the amount and kind of such Securities which such Warrant holder would have received if
such Warrant holder had, immediately prior to the record date for the distribution of the Securities, exercised this Warrant.

    	 	
2
	 

    	 

    

3.5.        
Warrant Price Adjustment. Whenever the number of shares of Common Stock issuable upon exercise of each Warrant is adjusted,
as herein provided, the Warrant Price payable upon the exercise of each Warrant shall be adjusted to that price determined by
multiplying the Warrant Price immediately prior to such adjustment by a fraction (i) the numerator of which shall be the number
of shares of Common Stock purchasable upon exercise of each Warrant immediately prior to such adjustment, and (ii) the denominator
of which shall be the number of shares of Common Stock purchasable upon exercise of each Warrant immediately thereafter.

3.6.        
Certain Shares Excluded. The number of shares of Common Stock outstanding at any given time for purposes of the adjustments
set forth in this Section 3 shall exclude any shares then directly or indirectly held in the treasury of the Company.

3.7.        
Deferral and Cumulation of De Minimis Adjustments. No adjustment shall be required pursuant to this Section 3 if the amount
of any adjustment would be less than one percent (1%) of the Warrant Price in effect immediately before the event that would otherwise
have given rise to such adjustment. In such case, however, any adjustment that would otherwise have been required to be made shall
be made at the time of and together with the next subsequent adjustment which, together with any adjustment or adjustments so
carried forward, shall amount to not less than one percent (1%) of the Warrant Price in effect immediately before the event giving
rise to such next subsequent adjustment.

3.8.        
Duration of Adjustment. Following each computation or readjustment as provided in this Section 3, the new adjusted Warrant
Price and number of shares of Common Stock issuable upon exercise of each Warrant shall remain in effect until a further computation
or readjustment thereof is required.

3.9.        
Notice of Record Date. In case:

3.9.1.    
the Company shall take a record of the holders of its Common Stock (or other stock or securities at the time receivable upon the
exercise of this Warrant) for the purpose of entitling them to receive any dividend (other than a cash dividend payable out of
earned surplus of the Company) or other distribution, or any right to subscribe for or purchase any shares of stock of any class
or any other securities, or to receive any other right;

3.9.2.    
or of any voluntary dissolution, liquidation or winding-up of the Company;

then, and in each
such case, the Company will mail or cause to be mailed to each Warrant holder hereof at the time outstanding a notice specifying,
as the case may be, (i) the date on which a record is to be taken for the purpose of such dividend, distribution or right, and
stating the amount and character of such dividend, distribution or right, or (ii) the date on which such reorganization, reclassification,
consolidation, merger, conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed,
as of which the holders of record of Common Stock (or such stock or securities at the time receivable upon the exercise of
this Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock or securities) for securities or
other property deliverable upon such reorganization, reclassification, consolidation, merger, conveyance, dissolution, liquidation
or winding-up. Such notice shall be mailed at least twenty (20) days prior to the record date therein specified, or if no record
date shall have been specified therein, at least twenty (20) days prior to the date of such action, provided, however, failure
to provide any such notice shall not affect the validity of such transaction.

3.10.     
Certificate of Adjustment. Whenever any adjustment shall be made pursuant to Section 3 hereof, the Company shall promptly
make a certificate setting forth in reasonable detail the event requiring the adjustment, the amount of the adjustment, the method
by which such adjustment was calculated and the Warrant Price and number of shares of Common Stock purchasable upon exercise
of this Warrant after giving effect to such adjustment, and shall promptly cause copies of such certificate to be mailed (by first
class mail, postage prepaid) to the Warrant holders.

3.11.     
Form of Warrant. The Warrant Certificate need not be changed because of any adjustment pursuant to this Section 3, and
Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants
initially issued pursuant to this Agreement. However, the Company may at any time in its sole discretion make any change in the
Warrant Certificate that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so
changed.

    	 	
3
	 

    	 

    

4.    
Transfer of Warrants.

4.1.        
Restricted Securities. The Warrants and Common Stock to be issued upon exercise are restricted securities and may not be
transferred except in full compliance with applicable securities laws.

5.    
Other Provisions Relating to Rights of Holders of Warrants.

5.1.        
No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder
of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive
rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of
directors of the Company or any other matter.

5.2.        
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and
the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case
of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant
so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

5.3.        
Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this
Agreement.

6.    
Miscellaneous Provisions.

6.1.        
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company shall bind and inure
to the benefit of their respective successors and assigns.

6.2.        
Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the holder of any
Warrant or the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified
mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Company as follows:

5734 Yonge Street,
Suite 300

Toronto, Ontario
M2M 4E7

Attn:Chief Executive Officer

 

Any notice, statement
or demand authorized by this Agreement to be given or made by the holder shall be sufficiently given when so delivered if by hand
or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage
prepaid, addressed (until another address is filed in writing by the Warrant Holder as follows:

 

Warrant Holder

 

6.3.        
Applicable law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in
all respects by the laws of the State of Colorado, without giving effect to conflicts of law principles that would result in the
application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against
it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of Colorado
or the United States District Court in Denver, Colorado, and irrevocably submits to such jurisdiction, which jurisdiction shall
be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenience
forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or
certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such
mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim.

    	 	
4
	 

    	 

    

6.4.        
Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any
of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than
the parties hereto and the registered holders of the Warrants any right, remedy, or claim under or by reason of this Warrant Agreement
or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and
agreements contained in this Warrant Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors
and assigns and of the registered holders of the Warrants.

6.5.        
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office
of the Company, for inspection by the registered holder of any Warrant.

6.6.        
Counterparts. This Agreement may be executed in any number of counterparts and each of such counterparts shall for all
purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

6.7.        
Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and
shall not affect the interpretation thereof.

6.8.        
Amendments.This Agreement may not be altered, amended, or modified, nor may any provision hereof be waived except in
a written instrument signed by the Company and the Warrant Agent.

 

IN WITNESS WHEREOF,
this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

GREENESTONE
HEALTHCARE CORPORATION

 

 

BY:_______________________________________

SHAWN LEON

PRESIDENT

  

 

    	 	
5
	 

    	 

    

SCHEDULE A

  

THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION
FROM THE REQUIREMENTS FOR SUCH REGISTRATION FOR NONPUBLIC OFFERINGS. ACCORDINGLY, THE SALE, TRANSFER, PLEDGE, HYPOTHECATION OR
OTHER DISPOSITION OF THE SECURITIES EVIDENCED HEREBY OR ANY PORTION THEREOF OR INTEREST THEREIN MAY NOT BE ACCOMPLISHED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY IN FORM AND SUBSTANCE TO THE
COMPANY TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.

 

VOID AFTER 5:00 P.M., EASTERN TIME ON DECEMBER
, 2019

 

 

WARRANT

 

Number: _____

 

For the Purchase of _______

Shares of Common Stock, $.01 Par Value

of GREENESTONE HEALTHCARE COPORATION, a
Colorado Corporation 

by ________________

 

THIS CERTIFIES THAT, for value received, GREENESTONE
HEALTHCARE CORPORATION,  a Colorado Corporation, located at 5734 Yonge Street, Suite 300, Toronto,
Ontario M2M (The "Company")  and the Company hereby agrees to issue this Warrant to _______________ and/or its/her/his
assigns (referred to herein as the “Buyer”) to purchase _______________________________________ (____________) of
such voting common shares of the Company. (the “Warrant”), at a price of $0.03 per share (referred to herein as the
“Exercise Price”), exercisable in whole or in part by the Buyer at any time or from time to time after December 30,
2016, and before 5:00 P.M., Eastern Time, December 30th, 2019, but not thereafter (the “Warrant Exercise Term”).
Upon presentation and surrender of this Warrant and upon payment of the Exercise Price for such shares of the Common Stock of
the Company at the principal office of the Company, but subject to the conditions set forth in the Warrant Agreement; provided,
however, that upon the occurrence of any of the events specified in the Warrant Agreement, the rights granted by this Warrant
shall be adjusted as therein specified. Payment of the Exercise Price may be made in cash, by cashier’s check, wire transfer
or Cashless Exercise as provided in the Warrant Agreement. Upon exercise of this Warrant, the form of election hereinafter provided
for in Schedule B must be duly executed and the instructions for registration of the Common Stock acquired by such exercise
must be completed. If the subscription rights represented hereby shall not be exercised at or before 5:00 P.M., Pacific Time,
on December 30, 2019, this Warrant shall become and be void without further force or effect, and all rights represented
hereby shall cease and expire.

 

This Warrant may be exercised in accordance
with its terms in whole or in part. In the event of the exercise or assignment hereof in part only, the Company shall cause to
be delivered to the Holder a new Warrant of like tenor to this Warrant in the name of the Holder representing the number of shares
with respect to which this Warrant shall not then have been exercised.

 

In no event shall this Warrant (or the shares
of the Common Stock issuable upon full or partial exercise hereof) be offered or sold except in conformity with the Securities
Act of 1933, as amended.

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be signed by its duly authorized officer as of December 30, 2016.

 

 

GreeneStone Healthcare Corporationa Colorado
corporation

 

 

________________________________

By: Shawn Leon

President

 

    	 	
6
	 

    	 

    

SCHEDULE B

 

Form to be used to exercise Warrant:

 

TO:GREENESTONE HEALTHCARE CORPORATION

 

DATE: ________________________________

 

The Undersigned hereby elects irrevocably to exercise the within
Warrant and to purchase  shares of the Common Stock of Certified, Inc. called for thereby, and hereby makes payment
by:

 

(check one)

 

 [ ] Cashier’s check of $ (at the rate of
$0.03 per share of Common Stock) in payment of the Exercise Price pursuant thereto;

 

[ ] Wire transfer of $______________(at the rate of $0.03 per
share of Common Stock) in payment of the Exercise Price pursuant thereto; or

 

[ ] Cashless Exercise.

 

Please issue the shares of Common Stock as to which this Warrant
is exercised in the name of:

 

___________________       

(Name)

_____________________

(Address)

__________________

(Taxpayer Number)

 

and if said number of Warrants shall not be all the Warrants evidenced
by the within Warrant Certificate, issue a new Warrant Certificate for the balance remaining of such Warrants to the undersigned
at the address stated below.

 

Name of Holder: ___________________________

(Please Print)

 

Signature: _________________________________

 

____________________________________

(Address)

 

NOTICE: The signature to the form to exercise
must correspond with the name as written upon the face of the within Warrant in every particular without alteration or enlargement
or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having
membership on a registered national securities exchange.

 

    	 	
7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]